Market Place
Sourcing Support
All News #Library
Others
Tubulis Names Charles Fuchs, MD as Chief Medical Officer
08 Jan 2026 //
PHARMIWEB
Tubulis To Present At J.P. Morgan Healthcare Conference
16 Dec 2025 //
BUSINESSWIRE
Tubulis Announces Closing of Series C, Total Raised to €344M
30 Oct 2025 //
BUSINESSWIRE
Tubulis Appoints Halley as Chief Legal and Operating Officer
09 Sep 2025 //
BUSINESSWIRE
Tubulis Appoints Matthew Norkunas as CFO & President
06 Feb 2025 //
BUSINESSWIRE
Tubulis Doses First Patient In ADC TUB-030 Solid Cancer Trial
30 Jan 2025 //
BUSINESSWIRE
Tubulis to Present at 43rd J.P. Morgan Healthcare Conference
17 Dec 2024 //
BUSINESSWIRE
Fierce Biotech Names Tubulis a "Fierce 15" Biotech Company of 2024
05 Aug 2024 //
BUSINESSWIRE
Tubulis Closes €60 Million Series B Financing
03 May 2022 //
BUSINESSWIRE
Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead
20 Apr 2021 //
BUSINESSWIRE
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA
02 Dec 2020 //
PRNEWSWIRE
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA
01 Dec 2020 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.